Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Go back to Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights| (NASDAQ: CADL) | Delayed: 12.22 -0.38 (3.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.60 | 52 Week High | $ | |||
| Open | $12.52 | 52 Week Low | $ | |||
| Day High | $12.78 | P/E | N/A | |||
| Day Low | $12.20 | EPS | $ | |||
| Volume | 438,976 | |||||

